Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab: a Pilot Study
Phase of Trial: Phase II
Latest Information Update: 26 Oct 2017
At a glance
- Drugs Reslizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 19 Oct 2017 Planned End Date changed from 28 Feb 2018 to 31 Mar 2018.
- 19 Oct 2017 Planned primary completion date changed from 31 Dec 2017 to 31 Mar 2018.
- 04 May 2017 Status changed from not yet recruiting to recruiting.